The latest research reveals that recombinant thrombomodulin (rTM) exerts a protective effect against sepsis by inhibiting the HIF-1α/METTL3/PFKM axis and promoting the transformation of macrophages to an anti-inflammatory phenotype (85). This evidence concerns the gene HIF1A and Sepsis.